US Patent Issued to CEVA SANTE ANIMALE on June 16 for "Vaccine composition against Streptococcus suis infection" (German Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,878, issued on June 16, was assigned to CEVA SANTE ANIMALE S.A. (Libourne, France).

"Vaccine composition against Streptococcus suis infection" was invented by Jana Seele (Hannover, Germany), Christoph Baums (Leipzig, Germany) and Peter Valentin-Weigand (Iisede, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described is a vaccine composition comprising an effective amount of at least one polypeptide selected from the group of IdeSsuis, rIdeSsuis, an analogue or a fragment thereof, or a polynucleotide encoding the same. This vaccine composition is used in the prophylactic, metaphylactic or therapeutic treatment of a Streptococcus suis infecti...